Cancer Therapies Could Be Improved By Using Precious Metal Flecks as Catalysts

by Jeffil Obadiah on  September 11, 2019 at 11:24 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

Cancer therapies could be revolutionized by implementing tiny extracts of a precious metal.

Researchers have found a way to dispatch minute fragments of palladium - a key component in motor manufacture, electronics, and the oil industry - inside cancerous cells.
Cancer Therapies Could Be Improved By Using Precious Metal Flecks as Catalysts
Cancer Therapies Could Be Improved By Using Precious Metal Flecks as Catalysts

Scientists have long known that the metal, used in catalytic converters to detoxify exhaust, could be used to aid cancer treatment but, until now, have been unable to deliver it to affected areas.

Show Full Article


A molecular shuttle system that targets specific cancer cells has been created by a team at the University of Edinburgh and the Universidad de Zaragoza in Spain.

The new method, which exploits palladium's ability to accelerate - or catalyze - chemical reactions, mimics the process some viruses use to cross cell membranes and spread infection.

The team has used bubble-like pouches that resemble the biological carriers known as exosomes, which can transport essential proteins and genetic material between cells. These exosomes exit and enter cells, dump their content and influence how the cells behave.

This targeted transport system, which is also exploited by some viruses to spread the infection to other cells and tissues, inspired the team to investigate their use as shuttles of therapeutics.

The researchers have now shown that this complex communication network can be hijacked. The team created exosomes derived from lung cancer cells and cells associated with glioma - a tumor that occurs in the brain and spinal cord - and loaded them with palladium catalysts.

These artificial exosomes act as Trojan horses, taking the catalysts - which work in tandem with an existing cancer drug- straight to primary tumors and metastatic cells.

Having proved the concept in laboratory tests, the researchers have now been granted a patent that gives them exclusive rights to trial palladium-based therapies in medicine.

The study was funded by the Engineering and Physical Sciences Research Council and the European Research Council. It has been published in the journal, Nature Catalysis.

Professor Asier Unciti-Broceta, from the University of Edinburgh's CRUK Edinburgh Centre, said: "We have tricked exosomes naturally released by cancer cells into taking up a metal that will activate chemotherapy drugs just inside the cancer cells, which could leave healthy cells untouched."

Professor Jesús Santamaría, of the Universidad de Zaragoza, said: "This has the potential to be a very exciting technology. It could allow us to target the main tumor and metastatic cells, thus reducing the side effects of chemotherapy without compromising the treatment."

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive